Indeed. That's what I keep wondering as the sp gets played down...

First 4 Last

Share
Profile

Follow
m123456

1,334 Posts.

22

11/11/18

23:51

Post #: 36464781
Share

Originally posted by skint ↑

Originally posted by pivalde
Skint, very interesting drug. To understand it a bit more I post here how it works. As you can see it does not prevent death of brain cells as I do hope PBT434 does in humans and has been demonstrated to be true in animal studies. Best to read it your self:
"The progressive motor symptoms of Parkinson’s disease are largely due to the death of dopamine neurons in the substantia nigra, a part of the midbrain that converts levodopa to dopamine, in a single step catalyzed by the enzyme AADC. Neurons in the substantia nigra release dopamine into the putamen where the receptors for dopamine reside. In Parkinson’s disease, neurons in the substantia nigra degenerate and the enzyme AADC is markedly reduced in the putamen, which limits the brain’s ability to convert oral levodopa to dopamine4. The intrinsic neurons in the putamen, however, do not degenerate in Parkinson’s disease5,6. VY-AADC, comprised of the adeno-associated virus-2 capsid and a cytomegalovirus promoter to drive AADC transgene expression, is designed to deliver the AADC gene directly into neurons of the putamen where dopamine receptors are located, bypassing the substantia nigra neurons and enabling the neurons of the putamen to express the AADC enzyme to convert levodopa into dopamine. The approach with VY-AADC, therefore, has the potential to durably enhance the conversion of levodopa to dopamine and provide clinically meaningful improvements by restoring motor function in patients and improving symptoms following a single administration".
Yes I agree, VY-AADC is a totally different class of drug, and the action of PBT434 of the rescue of failing SN neurons would seem to be superior. I do like the way Voyager was able to deliver some efficacy results from the phase 1 trials.
With cash close to 200m and market cap of 400m Voyager have an enterprise value of around 200m. I think it is amazing no Pharmas are interested in Prana at this very low price.

Expand

Indeed. That's what I keep wondering as the sp gets played down lower and lower as we head towards christmas with all time lows plausible before then.

Is there something all of us are totally missing?

PBT Price at posting: 4.3¢ Sentiment: Hold Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

AXP

Tambourah chases gold veins and mineralisation extension with drilling

There are more pages in this discussion • 4 more messages in this thread...

First 4 Last

Add PBT (ASX) to my watchlist

Indeed. That's what I keep wondering as the sp gets played down...

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

Tambourah chases gold veins and mineralisation extension with drilling

Featured News